Lunit - 2026 Pricing, Features, Reviews & Alternatives

Lunit is a modular medical AI software platform covering cancer detection, diagnosis, treatment planning, and drug development workflows. Designed for radiologists, oncologists, pathologists, and pharmaceutical researchers, Lunit integrates with existing clinical infrastructure to deliver AI-assisted analysis across imaging and pathology data. Deployment options support both hospital networks and research environments, with configurations adaptable to institutional scale and specialty focus.

Lunit addresses the full oncology care continuum. On the imaging side, the platform analyzes chest X-rays and mammograms to flag suspicious findings, stratify risk, and support radiologist review. On the pathology side, Lunit processes whole-slide images to quantify biomarkers, assess tumor microenvironments, and generate spatial data relevant to treatment selection. For pharmaceutical applications, Lunit provides digital pathology analytics that accelerate biomarker discovery and clinical trial workflows, reducing reliance on manual slide review.

Across all modules, Lunit applies AI models trained on large-scale, clinically validated datasets. The platform is cleared or approved by major regulatory bodies including the FDA, CE, and MFDS, supporting deployment in regulated clinical settings. Integration with PACS, LIS, and other health IT systems allows Lunit to fit into established diagnostic pipelines without requiring significant infrastructure changes. The result is a comprehensive AI layer that augments clinical decision-making across radiology, pathology, and oncology drug development.